Buy Retatrutide 40mg

A 40mg Retatrutide formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation.

Retatrutide is a triple agonist weight-loss drug being developed for obesity and other weight-related conditions. It is a once-weekly injection designed to target three receptors involved in appetite and metabolism: GIP, GLP-1, and glucagon. Because it activates all three, Retatrutide is often referred to as a “Triple G” weight-loss medication or a triple hormone receptor agonist.

Retatrutide may support weight loss by:

• reducing appetite
• increasing feelings of fullness
• slowing digestion
• increasing energy expenditure
• improving fat breakdown
• reducing fat storage

How Does Retatrutide Work?

Retatrutide is a triple hormone receptor agonist in development for the treatment of obesity. It works by targeting three different hunger- and metabolism-related hormones: GIP, GLP-1, and GCG (glucagon).

Retatrutide delivered major weight loss in TRIUMPH-4 (NCT05869903), with average weight reductions of 26.4% at 9 mg and 28.7% at 12 mg.

That translated to about:

• 64.2 lbs (29.1 kg) lost with Retatrutide 9 mg
• 71.2 lbs (32.3 kg) lost with Retatrutide 12 mg

By comparison, the placebo produced only 2.1% weight loss.

A high proportion of participants taking Retatrutide achieved clinically meaningful weight loss:

• 25% or more weight loss: 47.7% to 58.6%
• 30% or more weight loss: 30.5% to 39.4%*
• 35% or more weight loss: 18.2% to 23.7%*

Up to 73.0% of Retatrutide 9 mg participants achieved at least a 70% reduction in WOMAC pain, compared with 26.2% on placebo.

Retatrutide Side Effects

The most commonly reported Retatrutide side effects so far have been:

• nausea
• diarrhea
• vomiting
• constipation

retatrutide 40mg pen price uk

Approximately £180. This price reflects a verified, batch-tested 40mg Retatrutide pen dispatched from UK stock.